Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M WOODY

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2012
Dissecting the substrate recognition of 3-O-sulfotransferase for the biosynthesis of anticoagulant heparinAndrea F Moon, Yongmei Xu, Susan M Woody, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Biochemical and antitumor activity of trimidox, a new inhibitor of ribonucleotide reductaseT Szekeres, K Gharehbaghi, M Fritzer, et al.
International Journal of Radiation Oncology, Biology, Physics|July 13, 2014
30 Gy or 34 Gy? Comparing 2 single-fraction SBRT dose schedules for stage I medically inoperable non-small cell lung cancerGregory M M Videtic, Kevin L Stephans, Neil M Woody, et al.
Blood|May 30, 2008
Expression, activation, and function of integrin alphaMbeta2 (Mac-1) on neutrophil-derived microparticlesElzbieta Pluskota, Neil M Woody, Dorota Szpak, et al.
Practical Radiation Oncology|March 29, 2014
Stereotactic body radiation therapy-based treatment model for stage I medically inoperable small cell lung cancerGregory M M Videtic, Kevin L Stephans, Neil M Woody, et al.
Molecular and Cellular Biology|April 25, 2007
Analysis of a Shc family adaptor protein, ShcD/Shc4, that associates with muscle-specific kinaseNina Jones, W Rod Hardy, Matthew B Friese, et al.
International Journal of Radiation Oncology, Biology, Physics|January 23, 2018
Tumor Control and Toxicity for Common Stereotactic Body Radiation Therapy Dose-Fractionation Regimens in Stage I Non-Small Cell Lung CancerKevin L Stephans, Neil M Woody, Chandana A Reddy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 26, 2016
Isolated Nodal Failure after Stereotactic Body Radiotherapy for Lung Cancer: The Role for Salvage Mediastinal RadiotherapyMatthew C Ward, Steven C Oh, Yvonne D Pham, et al.
International Journal of Radiation Oncology, Biology, Physics|January 29, 2020
Validation of RTOG 0813 Proximal Bronchial Tree Constraints for Pulmonary Toxicity With Stereotactic Body Radiation Therapy for Central Non-small Cell Lung CancerBindu V Manyam, Kyle Verdecchia, Gregory M M Videtic, et al.
International Journal of Radiation Oncology, Biology, Physics|July 13, 2014
Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicityKevin L Stephans, Toufik Djemil, Claudiu Diaconu, et al.
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2012
Dissecting the substrate recognition of 3-O-sulfotransferase for the biosynthesis of anticoagulant heparinAndrea F Moon, Yongmei Xu, Susan M Woody, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Biochemical and antitumor activity of trimidox, a new inhibitor of ribonucleotide reductaseT Szekeres, K Gharehbaghi, M Fritzer, et al.
International Journal of Radiation Oncology, Biology, Physics|July 13, 2014
30 Gy or 34 Gy? Comparing 2 single-fraction SBRT dose schedules for stage I medically inoperable non-small cell lung cancerGregory M M Videtic, Kevin L Stephans, Neil M Woody, et al.
Blood|May 30, 2008
Expression, activation, and function of integrin alphaMbeta2 (Mac-1) on neutrophil-derived microparticlesElzbieta Pluskota, Neil M Woody, Dorota Szpak, et al.
Practical Radiation Oncology|March 29, 2014
Stereotactic body radiation therapy-based treatment model for stage I medically inoperable small cell lung cancerGregory M M Videtic, Kevin L Stephans, Neil M Woody, et al.
Molecular and Cellular Biology|April 25, 2007
Analysis of a Shc family adaptor protein, ShcD/Shc4, that associates with muscle-specific kinaseNina Jones, W Rod Hardy, Matthew B Friese, et al.
International Journal of Radiation Oncology, Biology, Physics|January 23, 2018
Tumor Control and Toxicity for Common Stereotactic Body Radiation Therapy Dose-Fractionation Regimens in Stage I Non-Small Cell Lung CancerKevin L Stephans, Neil M Woody, Chandana A Reddy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 26, 2016
Isolated Nodal Failure after Stereotactic Body Radiotherapy for Lung Cancer: The Role for Salvage Mediastinal RadiotherapyMatthew C Ward, Steven C Oh, Yvonne D Pham, et al.
International Journal of Radiation Oncology, Biology, Physics|January 29, 2020
Validation of RTOG 0813 Proximal Bronchial Tree Constraints for Pulmonary Toxicity With Stereotactic Body Radiation Therapy for Central Non-small Cell Lung CancerBindu V Manyam, Kyle Verdecchia, Gregory M M Videtic, et al.
International Journal of Radiation Oncology, Biology, Physics|July 13, 2014
Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicityKevin L Stephans, Toufik Djemil, Claudiu Diaconu, et al.
Pageof 9